Definition
Inappropriate concentric hypertrophy of the ventricular free wall and/or the interventricular septum of the non-dilated left ventricle. The disease occurs independently of other cardiac or systemic disorders.
Pathophysiology
Systems Affected
Genetics
Some families of cats have been identified with a high prevalence of the disease, and the disease appears to be an autosomal dominant trait in Maine coon cats and ragdoll cats, due to a mutation in the MyBPC gene. The genetics have not been definitively determined in other breeds; however, the Maine coon and ragdoll mutations have not been identified in affected Sphynx, Norwegian forest cats, Bengals, Siberians, or British shorthair cats.
Incidence/Prevalence
Unknown, but relatively common. May be as high as 15% of the population.
Signalment
Species: Cat
Breed Predilections
Maine coon cats, ragdolls, Sphynx, British and American shorthairs, and Persians.
Mean Age and Range
57 years with reported ages of 3 months17 years. Some breeds of cats including ragdolls and Sphynx may develop the disease at a younger age (average of 2 years of age). HCM is most often a disease of young to middle-aged cats; unexplained murmurs in geriatric cats are more likely associated with hyperthyroidism or hypertension.
Predominant Sex: Male
Signs
Historical Findings
Physical Examination Findings
Causes
Possible Causes
Risk Factors
Offspring of animals with familial mutations of MyBPC
Differential Diagnosis
CBC/Biochemistry/Urinalysis
Other Laboratory Tests
Imaging
Radiography
Echocardiography
Diagnostic Procedures
Electrocardiography
Systemic Blood Pressure
Pathologic Findings
Appropriate Health Care
Cats with CHF should be hospitalized.
Nursing Care
Activity
Restricted with CHF
Diet
Modest to moderate sodium restriction in animals with CHF
Chf Client Education
Drug(s) Of Choice
Pimobendan
ACE Inhibitors
Beta-Blockers
Diltiazem
Aspirin
Nitroglycerin Ointment
Contraindications
Avoid beta-blockers in cats with emboli; these agents cause peripheral vasoconstriction. If beta-blockers must be used in this setting for arrhythmia control, choose a beta-1 selective blocker such as atenolol.
Precautions
Use ACE inhibitors cautiously in azotemic animals.
Alternative Drug(s)
Warfarin and Low Molecular Weight Heparin
Clopidogrel
Dosage-18.75 mg/cat/day. Platelet function inhibitor, superior to aspirin in cats with previous ATE.
Beta-Blocker Plus Diltiazem
Patient Monitoring
Prevention/Avoidance
Avoid stressful situations that might precipitate CHF.
Possible Complications
Expected Course and Prognosis
Associated Conditions
Aortic thromboembolism
Pregnancy/Fertility/Breeding
See Also
Abbreviations
Authors Francis W.K. Smith, Jr., Bruce W. Keene, and Kathryn M. Meurs
Client Education Handout Available Online